Bøker i Pediatric Oncology-serien

This textbook is the first to focus on comprehensive interdisciplinary care approaches aimed at enhancing the wellbeing of children with cancer and their families throughout the illness experience.

This book is a comprehensive guide that will help medical professionals - pediatric oncologists, nurses, pediatricians, family practitioners, internists, radiation oncologists, surgeons - to understand and manage the long-term effects of treatment for childhood and adolescent cancer.

This book, co-authored by an internationally acclaimed team of experts in the field of pediatric oncologic imaging, provides a comprehensive update on new advances in diagnostic imaging as they relate to pediatric oncology.

This book provides a thorough and up-to-date discussion of key issues in the supportive care of children with cancer. Supportive Care in Pediatric Oncology will be an invaluable source of assistance for a wide range of health professionals involved in pediatric cancer care.

More recently, address all those important aspects of retinoblastoma the treatment of children with retinoblastoma has also research and therapy - from biology to epidemiology provided a model for modern approach to the can- to treatment.

This book is a comprehensive guide that will help medical professionals - pediatric oncologists, nurses, pediatricians, family practitioners, internists, radiation oncologists, surgeons - to understand and manage the long-term effects of treatment for childhood and adolescent cancer.

This book covers a broad spectrum of complementary and alternative medicine (CAM) practices employed in pediatric oncology worldwide, with a special focus on the methods widely used in Western countries.

This textbook is the first to focus on comprehensive interdisciplinary care approaches aimed at enhancing the wellbeing of children with cancer and their families throughout the illness experience.

This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, the book describes the steps in the process from the identification of a promising therapeutic target to the evaluation of drug candidates in the various phases of clinical testing and regulatory review. Throughout, special emphasis is placed on the unique biology of pediatric malignancies and the medical and social needs of children and their families. In providing a firm grounding in the drug development process, the book will be of value to all with an interest in how medicines currently used to treat pediatric cancer were made available. This includes trainees as well as established practitioners and others participating in translational and clinical research in the academic setting.